Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
NRP2 (human)

Overview
NRP2 High affinity receptor for semaphorins 3C, 3F, VEGF-165 and VEGF-145 isoforms of VEGF, and the PLGF-2 isoform of PGF. Heterodimer with NRP1. Binds PLXNB1. Belongs to the neuropilin family. 5 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Receptor, misc.; Membrane protein, integral; Motility/polarity/chemotaxis
Cellular Component: membrane; axon; plasma membrane; integral to membrane
Molecular Function: heparin binding; vascular endothelial growth factor receptor activity; semaphorin receptor activity; growth factor binding; metal ion binding; cytokine binding; receptor activity
Biological Process: axon guidance; heart development; negative chemotaxis; positive regulation of endothelial cell proliferation; angiogenesis; cell adhesion; vascular endothelial growth factor receptor signaling pathway; neural crest cell migration
Reference #:  O60462 (UniProtKB)
Alt. Names/Synonyms: MGC126574; neuropilin 2; Neuropilin-2; neuropilin-2a(17); neuropilin-2a(22); neuropilin-2b(0); NP2; NPN2; NRP2; PRO2714; receptor for VEGF165 and semaphorins class3; Vascular endothelial cell growth factor 165 receptor 2; vascular endothelial growth factor-165 receptor 2; VEGF165R2
Gene Symbols: NRP2
Molecular weight: 104,859 Da
Basal Isoelectric point: 5.04  Predict pI for various phosphorylation states
Select Structure to View Below

NRP2

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  RCSB PDB  |  Phospho3D  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

► Hide Isoforms
 
0 1 S454 DSQISASSTQEYLWS
0 1 - gap
  NRP2 iso5  
S454 DSQISASSTQEYLWS
Y882-p ITYKTSHyTNGAPLA
  mouse

► Hide Isoforms
 
S454-p DTQISASsTREYLWS
- gap
  NRP2 iso5  
S454 DTQISASSTREYLWS
Y877 ITYKTSHYTNGAPLA
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.